Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: May 24, 2023
Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients.
Journal: Clinical pharmacology and therapeutics
Published: March 21, 2021
Advances in the Development of Therapeutics for Cytomegalovirus Infections.
Journal: The Journal of infectious diseases
Published: March 06, 2020
Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: October 25, 2019
Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.
Journal: The Journal of infectious diseases
Published: July 10, 2019
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 05, 2019
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
Journal: The New England journal of medicine
Published: December 07, 2017
Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.
Journal: Open forum infectious diseases
Published: December 30, 2015
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 06, 2014
Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.
Journal: Annals of internal medicine
Published: October 07, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
Journal: Annals of internal medicine
Published: October 07, 2014
Last Updated: 09/26/2026